Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

Garnett H. Kelsoe

James B. Duke Distinguished Professor of Immunology
Integrative Immunobiology
Room 2243 Duke@RTP, 27 Alexandria Way, Durham, NC 27703
Room 2243 Duke@RTP, 27 Alexandria Way, Durham, NC 27703

Overview


1. Lymphocyte development and antigen-driven diversification of immunoglobulin and T cell antigen receptor genes.
2. The germinal center reaction and mechanisms for clonal selection and self - tolerance. The origins of autoimmunity.
3. Interaction of innate- and adaptive immunity and the role of inflammation in lymphoid organogenesis.
4. The role of secondary V(D)J gene rearrangment in lymphocyte development and malignancies.
5. Mathematical modeling of immune responses, DNA motifs, collaborations in bioinformatics.
6. Humoral immunity to influenza and HIV-1.

Current Appointments & Affiliations


James B. Duke Distinguished Professor of Immunology · 2001 - Present Integrative Immunobiology, Basic Science Departments
Professor of Integrative Immunobiology · 1998 - Present Integrative Immunobiology, Basic Science Departments
Associate Professor in the Department of Surgery · 2020 - Present Surgery, Surgical Sciences, Surgery
Member of the Duke Cancer Institute · 1998 - Present Duke Cancer Institute, Institutes and Centers
Member of the Duke Human Vaccine Institute · 2006 - Present Duke Human Vaccine Institute, Institutes and Centers

Recent Publications


Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.

Journal Article Proc Natl Acad Sci U S A · January 2, 2024 Phylogenetically and antigenically distinct influenza A and B viruses (IAV and IBV) circulate in human populations, causing widespread morbidity. Antibodies (Abs) that bind epitopes conserved in both IAV and IBV hemagglutinins (HAs) could protect against d ... Full text Link to item Cite

A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses.

Journal Article PLoS Biol · December 2023 Antibody titers that inhibit the influenza virus hemagglutinin (HA) from engaging its receptor are the accepted correlate of protection from infection. Many potent antibodies with broad, intra-subtype specificity bind HA at the receptor binding site (RBS). ... Full text Link to item Cite
View All Publications

Recent Grants


Characterizing olfactory plasma cell dynamics and survival niche within the upper airway

ResearchCollaborator · Awarded by National Institutes of Health · 2024 - 2029

Innovations in Functional B Cell Epitope Discovery

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

Stimulating Access to Research in Residency (StARR) - NIAID

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029

View All Grants

Education, Training & Certifications


Harvard University · 1979 D.Sc.
Harvard University · 1975 M.S.